Endoscopic Submucosal Dissection for Esophageal Cancer: Current and Future
Yuki Okubo, Ryu Ishihara
Abstract
Endoscopic submucosal dissection (ESD) has been widely used to treat superficial esophageal cancer. The advantages of esophageal ESD include a high en bloc resection rate and accurate pathological diagnosis. It enables local resection of the primary tumor and accurate identification of the risk factors for lymph node metastasis, including depth, vascular invasion, and types of invasion. Even in cases with clinical T1b-SM cancer, ESD and additional treatment can achieve radical cure, depending on the risk of lymph node metastasis. Esophageal ESD will be increasingly vital in minimally invasive and effective esophageal cancer treatment. This article describes the current status and prospects of esophageal ESD.
Topics & Concepts
Esophageal cancerMedicineEndoscopic submucosal dissectionEndoscopic mucosal resectionCancerDissection (medical)MetastasisPathologicalLymph node metastasisSurgeryRadiologyResectionInternal medicineEsophageal Cancer Research and TreatmentGastric Cancer Management and OutcomesMetastasis and carcinoma case studies